ArticleEndocrine-related cancer2023

Biomarker response to high-specific-activity I-131 meta-iodobenzylguanidine in pheochromocytoma/paraganglioma.

Camilo Jimenez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.